|
| 36652163 | Disparities in SARS-CoV-2 Infection by Race, Ethnicity, Language, and Social Vulnerability: Evidence from a Citywide Seroprevalence Study in Massachusetts, USA. | J Racial Ethn Health Disparities | 2024 |
| 37403670 | The Identification of Enteric Fever-Specific Antigens for Population-Based Serosurveillance. | J Infect Dis | 2024 |
| 36268576 | Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study. | Clin Infect Dis | 2023 |
| 38019932 | T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19. | Sci Transl Med | 2023 |
| 37783453 | Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1. | Am J Trop Med Hyg | 2023 |
| 37610182 | Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017. | Emerg Infect Dis | 2023 |
| 37646517 | Comparison of O-specific polysaccharide responses in patients following infection with <i>Vibrio cholerae</i> O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh. | mSphere | 2023 |
| 37274530 | Seroepidemiology for Enteric Fever: Emerging Approaches and Opportunities. | Open Forum Infect Dis | 2023 |
| 37205407 | Shigella O-specific polysaccharide functional IgA responses mediate protection against shigella infection in an endemic high-burden setting. | bioRxiv | 2023 |
| 37400283 | Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry. | Vaccine | 2023 |
| 36907197 | Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study. | Lancet Microbe | 2023 |
| 35311584 | The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients. | Microbiol Spectr | 2022 |
| 35587156 | Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19. | Virulence | 2022 |
| 35677078 | Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19. | Res Sq | 2022 |
| 35721426 | Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection. | IJID Reg | 2022 |
| 35720155 | Covishield vaccine induces robust immune responses in Bangladeshi adults. | IJID Reg | 2022 |
| 35750069 | Estimating typhoid incidence from community-based serosurveys: a multicohort study. | Lancet Microbe | 2022 |
| 36618409 | Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh. | Front Immunol | 2022 |
| 36578502 | Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh. | Front Immunol | 2022 |
| 35864532 | Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19. | Cardiovasc Diabetol | 2022 |
| 36286520 | Identifying Recent Cholera Infections Using a Multiplex Bead Serological Assay. | mBio | 2022 |
| 36286224 | Seroincidence of Enteric Fever, Juba, South Sudan. | Emerg Infect Dis | 2022 |
| 34982773 | Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh. | PLoS Negl Trop Dis | 2022 |
| 34855508 | Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain. | Science | 2022 |
| 33412089 | COVID-19-neutralizing antibodies predict disease severity and survival. | Cell | 2021 |
| 33910997 | Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera. | mSphere | 2021 |
| 33852783 | Case 11-2021: A 39-Year-Old Woman with Fever, Flank Pain, and Inguinal Lymphadenopathy. | N Engl J Med | 2021 |
| 33879588 | Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of <i>Vibrio cholerae</i> O-Specific Polysaccharide-Specific Monoclonal Antibodies. | mBio | 2021 |
| 33872211 | Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine. | Am J Trop Med Hyg | 2021 |
| 33758900 | Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study. | medRxiv | 2021 |
| 33589825 | Humoral signatures of protective and pathological SARS-CoV-2 infection in children. | Nat Med | 2021 |
| 34842841 | Systemic, Mucosal, and Memory Immune Responses following Cholera. | Trop Med Infect Dis | 2021 |
| 34716040 | Scalable production and immunogenicity of a cholera conjugate vaccine. | Vaccine | 2021 |
| 34013872 | Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020<sup>1</sup>. | Emerg Infect Dis | 2021 |
| 34232076 | Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139. | mSphere | 2021 |
| 34280200 | Correction: Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh. | PLoS Negl Trop Dis | 2021 |
| 32511497 | Test performance evaluation of SARS-CoV-2 serological assays. | medRxiv | 2020 |
| 33033172 | Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. | Sci Immunol | 2020 |
| 33031941 | Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh. | Int J Infect Dis | 2020 |
| 33106822 | COVID-19 neutralizing antibodies predict disease severity and survival. | medRxiv | 2020 |
| 33326789 | HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound. | Cell Rep | 2020 |
| 33207184 | Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality. | Cell | 2020 |
| 33203761 | Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility. | mBio | 2020 |
| 32856766 | Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital. | FASEB J | 2020 |
| 32855547 | Evaluation of SARS-CoV-2 serology assays reveals a range of test performance. | Nat Biotechnol | 2020 |
| 32878931 | Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity. | mSphere | 2020 |
| 32897389 | Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease. | Clin Chem | 2020 |
| 32783920 | Distinct Early Serological Signatures Track with SARS-CoV-2 Survival. | Immunity | 2020 |
| 32948854 | Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19. | Nat Biomed Eng | 2020 |
| 32780998 | SARS-CoV-2-specific ELISA development. | J Immunol Methods | 2020 |